Subject: FW: COVAX AZ Delivery Update
From: Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G>
To: Amiran Gamkrelidze <[email-masked]>, Irma Khonelidze <[email-masked]>, Lia Jabidze <[email-masked]>, Khatuna Zakhashvili <[email-masked]>
Cc: Maia Nikoleishvili <[email-masked]>
Date: Mon, 22 Mar 2021 15:41:44 +0000

გთხოვთ გაეცნოთ

From: Rosie Grieves (Consultant) [mailto:[email-masked]]
Sent: 22 March, 2021 18:46
To: Tamar Gabunia
Cc: Maia Nikoleishvili ; Natia Khmaladze ; Alexander Khvtisiashvili ; [email-masked]; [email-masked]; [email-masked]
Subject: COVAX AZ Delivery Update

Dear Tamar,

I hope the rollout of the vaccine programme is going well.

We are writing to provide you with details on your initial delivery of doses of AstraZeneca AZD1222 vaccine for Q1, as part of your February to May 2021 allocation. Please find these details in the attached letter.

Thank you for your continued engagement with the Facility. We will continue to update you as more information becomes available on future shipments. Please do not hesitate to reach out to me or Unicef (on delivery dates) if you have any questions.

Best

Rosie

Rosie Grieves

Senior Manager Country Engagement

Mobile: +44 7849 574189

Web: gavi.org

NOTICE: This email, including any attachments to it, may be confidential and does not create any binding contract on behalf of Gavi or its partners.

If this email was sent to you in error, please notify the send